Pharmigene, Inc.

Pharmigene, Inc. is a biotechnology company specializing in the development, manufacturing, and distribution of molecular diagnostic tests. Founded in 1994 and headquartered in Taipei, the company focuses on providing genetic testing solutions that assist in detecting adverse drug reactions and enable pharmacogenomic profiling. Pharmigene’s product range includes diagnostic tools for clinical molecular diagnosis, DNA extraction, gene expression analysis, human identity testing, forensics, and biomedical research. In addition to its proprietary molecular diagnostics, the firm offers functional medicine and drug allergy testing services, along with contract development and manufacturing (CDMO) offerings. Pharmigene supports research and clinical laboratories through the supply of specialized equipment and reagents, while also delivering training and technical consulting. Its activities are integral to advancing personalized medicine, influencing drug safety, and improving healthcare outcomes in both domestic and international markets. The company serves a vital role in the healthcare sector by bridging biotechnology innovation with practical medical diagnostics and research applications.